Dapaflin 10mg Tablet
Marketer
Biotics Lab Life Services Private Limited
Salt Composition
Dapagliflozin (10mg)
Overview Dapaflin 10mg Tablet
Glycemia-10 tablets (10mg) are indicated, either monotherapy or in conjunction with other medications, for managing type 2 diabetes. This medication assists in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular health preservation. Glycemia-10 can be administered with or without food, at any time of day, although consistent daily timing is recommended. Dosage should be determined by your physician and must not be discontinued without their consultation; cessation may lead to hyperglycemia and the potential for severe consequences, such as nephropathy and visual impairment. This medication forms part of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections; dehydration is also possible. Adequate hydration is crucial; meticulous hygiene practices can minimize the risk of genital fungal infections. Prior to commencing treatment, discuss any pre-existing renal or hepatic conditions, urinary tract infections, or diuretic use with your physician. Pregnant or lactating individuals should seek medical advice before initiating therapy. Limit alcohol consumption during treatment to reduce the likelihood of adverse reactions. Regular blood glucose monitoring is essential during treatment.
Uses of Dapaflin 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapaflin 10mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid chewing, crushing, or fracturing it. Dapaflin 10mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapaflin 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaflin 10mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaflin 10mg Tablets can be consumed with or without food; however, consistent timing is recommended.
How Dapaflin 10mg Tablet works:
Glycemic control is achieved with Dapaflin 10mg tablets, an antidiabetic agent that facilitates urinary excretion of excess glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapaflin 10mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapaflin 10mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Dapaflin 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disorders should likely avoid Dapaflin 10mg tablets due to potential safety concerns. A physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver impairment can safely use Dapaflin 10mg tablets without requiring any dosage modification.
What if you forget to take Dapaflin 10mg Tablet :
Should you forget a Dapaflin 10mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapaflin 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |


